OasisLMS

JOPHON Courses offer continuing education created from JOPHON, APHON’s acclaimed journal. These courses feature original, peer-reviewed research aimed at enhancing clinical nursing care for children and adolescents with cancer and blood disorders, and their families.

This course aims to provide learners with a comprehensive understanding of the challenges and experiences faced by children undergoing 131I-MIBG therapy and their parents. The course will cover the high-risk nature of 131I-MIBG therapy, the necessity for single-room isolation, and the emotional and physical impacts on both children and parents. Learners will explore the methods used in the study, including data analysis techniques, and differentiate key findings related to the child and parent experiences. Additionally, the course will emphasize the clinical implications of the study, highlighting the importance of better education for families and the role of nurses in developing therapeutic relationships and implementing coping strategies.

• Describe the challenges of providing 131I-Metaiodobenzylguanidine (131I-MIBG) therapy to children with neuroblastoma.
• Describe the methods used to conduct this study, including data analysis techniques.
• Differentiate key findings related to the child and the parent experience identified in this study.
• Analyze and apply the study’s findings to improve care of children receiving 131I-MIBG therapy.

APHON will provide 1 nursing continuing professional development (NCPD) contact hour(s) for the successful completion of this course. Successful completion of:
JOPHON Article Review
Post-Test
Evaluation

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 NCPD in one of the following ILNA categories: Care Continuum, Psychosocial Dimensions of Care, OR Care of the Pediatric Hem/Onc Patient

 
The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513.

None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies.

Questions or concerns? Contact education@aphon.org.